Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10208354 NRG1 fusion genes in cancer
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
August 7, 2014
Date of Patent
February 19, 2019
Patent Application Number
14910639
Patent Citations Received
US Patent 11773170 Antibodies that bind EGFR and cMET
US Patent 11780925 ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
Patent Inventor Names
Lynnette Fernandez-Cuesta
0
Dennis Plenker
0
Julie George
0
Roman Thomas
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10208354
Patent Primary Examiner
Carla J. Myers
Find more entities like US Patent 10208354 NRG1 fusion genes in cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE